WELL Health Technologies Corp

WELL Health Technologies Corp WELL Health Technologies Corp. is an EMR service provider & operator of healthcare clinics in Canada

WELL is pleased to announce its majority-owned subsidiary Wellstar has entered into agreements to complete a Series B pr...
10/31/2025

WELL is pleased to announce its majority-owned subsidiary Wellstar has entered into agreements to complete a Series B preferred share investment in the aggregate amount of approximately C$62 million at an offering price of C$1.50 per Series B Share. Please read the key highlights below.

📌 WELLSTAR enters into subscription agreements to complete a C$62 million equity placement supported by Mawer Investment Management, Edgepoint Wealth Managemen, PICTON Investments and the management team of WELL and WELLSTAR to fund its pre-spinout growth objectives.

📌 The financing is anticipated to close early December, subject to certain closing conditions.

📌 WELLSTAR is a high growth, profitable, pure-play SaaS healthcare technology company serving over 40,000 providers across Canada with high quality technology and services that significantly improve patient care.

To learn more details, follow the link below. đź”—

https://ow.ly/w3pT50Xl60K

WELL will release Fiscal Third Quarter 2025 results before the market opens on Thursday, November 6, 2025. A conference ...
10/23/2025

WELL will release Fiscal Third Quarter 2025 results before the market opens on Thursday, November 6, 2025. A conference call and webcast will follow at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time), hosted by Hamed Shahbazi, Chairman and Chief Executive Officer, and Eva Fong, Chief Financial Officer. We welcome everyone to join us!

Follow the link below for webcast details.

https://ow.ly/UkQk50Xh323

Cantech Letter has published a feature article based on a research note by Stifel analyst Justin Keywood that suggests i...
10/03/2025

Cantech Letter has published a feature article based on a research note by Stifel analyst Justin Keywood that suggests investors revisit WELL Health (TSX: WELL) as a result of recent transactions and the early consolidation trend of Canadian healthcare assets.

The article suggests that WELL may be undervalued as Stifel maintains its “Buy” rating with a $9 target price, noting the company's strong growth strategy through clinic acquisitions and digital transformation. The article further highlights upcoming catalysts, including continued M&A of Canadian clinics, margin expansion, and the potential spin-out of its Wellstar digital SaaS platform.

Read the full article below.

https://ow.ly/yFzW50X5WKU

In September, our Chief Financial Officer, Eva Fong, hosted WELLs annual “Ask the CFO Anything” lunch with seven interns...
10/02/2025

In September, our Chief Financial Officer, Eva Fong, hosted WELLs annual “Ask the CFO Anything” lunch with seven interns. These second to fourth year students from the University of British Columbia, Queen's University, and University of Washington are pursuing studies in Finance, Business, Economics, and Artificial Intelligence Engineering - a mix of disciplines that reflects the breadth of skills required in modern digital healthcare.

Many have returned to their fall academic programs and continue contributing part-time, balancing rigorous coursework with meaningful professional contribution. 🚀

In that spirit, thank you, Eva, for creating space for open questions and candid dialogue. And thank you to our interns for the dedication, energy, and perspective you bring to WELL!

WELL and Wellstar are pleased to announce their joint participation at the upcoming 2025 Cantech Investment Conference o...
09/25/2025

WELL and Wellstar are pleased to announce their joint participation at the upcoming 2025 Cantech Investment Conference on Thursday, October 9, 2025, in Toronto, Ontario.

At the conference, Hamed Shahbazi, Founder & CEO of WELL, will discuss our capital-efficient growth strategy and the continued momentum across our business, while Amir Javidan, CEO of WELLSTAR, will introduce WELLSTAR to the investment community, showcasing its technological capabilities and financial performance.

Together, their presentations will underscore the complementary strengths of WELL and WELLSTAR in delivering significant improvements for providers and patients, and long-term value creation for shareholders.

Location: Arcadian Loft, 8th floor, 401 Bay Street, Toronto, ON
WELL: 1:30 PM EST | WELLSTAR: 4:00 PM EST

đź”— Learn more by following the link below.

https://ow.ly/J7hN50X2uFV

We’re proud to share that WELL Health has been recognized as the 2nd fastest-growing company in British Columbia by Busi...
09/12/2025

We’re proud to share that WELL Health has been recognized as the 2nd fastest-growing company in British Columbia by Business in Vancouver! This follows our #1 ranking last year and is a true reflection of the incredible work of our team, partners, and providers in advancing technology-enabled healthcare.

A big congratulations to all of the inspiring companies recognized this year - we’re honoured to be among such great company. Thank you to Business in Vancouver for shining a spotlight on growth and innovation across our province. Together, we’re building a stronger business community and healthier future for all Canadians!

đź”— Follow the link below to learn more.

https://ow.ly/S7yr50WWb05

WELL has been named a “Best Idea” in TD Cowen’s Canada Best Ideas 2025 report, with analyst David Kwan maintaining a Buy...
09/12/2025

WELL has been named a “Best Idea” in TD Cowen’s Canada Best Ideas 2025 report, with analyst David Kwan maintaining a Buy rating and a C$7.50 target price. 🚀

đź”— Read more by following the link below!

https://ow.ly/j7kG50WVx21

WELL is pleased to announce its interim consolidated financial results for the quarter ended June 30, 2025. Quarterly hi...
08/14/2025

WELL is pleased to announce its interim consolidated financial results for the quarter ended June 30, 2025.

Quarterly highlights:
âś… $356.7 million in revenue - an increase of 57% compared to Q2-2024.
âś… Record Adjusted EBITDA of $49.7 million in Q2-2025 - an increase of 231% compared to Q2-2024.
âś… 1.7 million patient visits in Q2-2025 - an increase of 21% compared to 1.4 million patient visits in Q2-2024.
🇨🇦 Over 1 million patient visits across its Canadian operations, a new quarterly milestone.

Hamed Shahbazi, Chairman and CEO of WELL commented, “I am very proud of our performance this quarter as it reflects a very significant milestone in our history with best-ever performances across most of our key financial metrics. We delivered record performances across Revenue, Adjusted EBITDA, Adjusted Net Income, and patient visits."

đź”— Read the full release below!

https://ow.ly/mXFL50WFWkq

The future of healthcare: intelligent, connected and caring. WELL's sustainability and impact program continues to evolv...
08/11/2025

The future of healthcare: intelligent, connected and caring. WELL's sustainability and impact program continues to evolve alongside the growth of our business.

As a healthcare technology company, we are committed to operating with integrity, protecting data and privacy, advancing inclusion and supporting a more resilient and intelligent healthcare ecosystem. To guide our efforts, we have developed a sustainability and impact framework and focus that reflects our core mission and integrates responsible business practices into how we govern, operate and grow. Read more below!

https://ow.ly/nt6j50WE3FV

WELL will release its Fiscal Second Quarter 2025 financial results for the period ended June 30, 2025, before the market...
07/28/2025

WELL will release its Fiscal Second Quarter 2025 financial results for the period ended June 30, 2025, before the market opens on Thursday, August 14, 2025. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 1:00 p.m. ET (10:00 a.m. PT).

For conference call details, check out WELL's latest PR.

https://ow.ly/UJuR50Ww5jr

WELL is pleased to share a corporate update on its majority-owned subsidiary, Wellstar highlighting continued strength a...
07/15/2025

WELL is pleased to share a corporate update on its majority-owned subsidiary, Wellstar highlighting continued strength across revenue growth, strategic acquisitions, and AI innovation.

WELLSTAR is ahead of internal expectations, raising its fiscal 2025 guidance to:

➡️ $74M total revenue
➡️ $22M in Adjusted EBITDA
➡️ $62M in total ARR, with an exit ARR of $80M — a 50% increase YoY

The company has also executed three LOIs expected to add:

➡️ $15M in ARR
➡️ $16M in revenue
➡️ $5M+ in Adjusted EBITDA (annualized)

WELLSTAR’s new Nexus AI™ solution is also gaining strong traction. As a pre-qualified vendor for Canada Health Infoway’s AI Scribe Program, eligible primary care providers can now receive a fully-funded Nexus AI license for 12 months.

More details here: https://ow.ly/IYQG50WpT3u

WELL is pleased to provide a corporate update highlighting continued growth and improved financial guidance for its Cana...
07/08/2025

WELL is pleased to provide a corporate update highlighting continued growth and improved financial guidance for its Canadian Clinics Business, progress on its M&A pipeline, the expansion of its RBC-led credit facility, and disclosure on a material cost optimization and efficiency initiative.

For more details, read WELL's latest PR.

https://ow.ly/TiWY50WmlXQ

Address

375 Water Street Suite 550
Vancouver, BC
V6B5C6

Alerts

Be the first to know and let us send you an email when WELL Health Technologies Corp posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram